Janux Therapeutics Officer Sells Shares
Meyer Andrew Hollman, Chief Business Officer of Janux Therapeutics, sold 3,334 shares of Common Stock on April 21, 2025, at a price of $30.0 per share, totaling $100,020. Following the transaction, Hollman directly owns 82,139 shares of the company. The sale was executed under a Rule 10b5-1 trading plan adopted on September 30, 2024.
SEC Filing:
Janux Therapeutics, Inc. [ JANX ] - Form 4 - Apr. 23, 2025
Reporter Name
Meyer Andrew Hollman
Relationship
Chief Business Officer
Type
Sell
Amount
$100,020
SEC Filing
Form 4